Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.Yao Anna became the brand ambassador of Baique Ling, and Baique Ling officially announced Yao Anna as the brand ambassador on December 11th.Iran's Supreme Leader Ayatollah Ali Khamenei vowed to expand Iran's axis of resistance in the Middle East.
Jizhi Co., Ltd.: Signed a supplementary agreement on development cooperation of 1.1 million yuan, and Jizhi Co., Ltd. announced that the company signed a supplementary agreement on entrusted development cooperation projects with Jiang Laboratory and Hangzhou Dilting Intelligent Technology Co., Ltd. According to the agreement, all parties have completed the development of intelligent underwater acoustic signal products, and will accelerate the application, promotion and industrialization of related products. The supplementary agreement stipulates that Jizhi shares will donate 1.1 million yuan to Zhejiang Zhijiang Development Foundation for public welfare. The signing of this agreement does not involve related party transactions, nor does it constitute a major asset restructuring. It still needs to be submitted to the company's second extraordinary shareholders meeting in 2024 for consideration. The signing of the agreement has limited impact on the company's short-term financial situation, but it is expected to have important strategic significance for the company's business development in the process of industrialization of related products.Huize released its Q3 results in 2024, and the number of insured customers exceeded 10 million. On December 10th, HUIZ.US, an insurance e-commerce service platform, released its unaudited Q3 results report in the third quarter of 2024 (hereinafter referred to as "Q3") before the opening of the US stock market. The data shows that during Q3, Huixuan contributed a total premium of 2.06 billion yuan (RMB, the same below), a total revenue of 370 million yuan and a net profit of 18.7 million yuan. After experiencing rapid growth since the reform and opening up, China's economy is entering a new normal of medium-speed development. In 2024, opportunities and challenges coexist in the insurance industry. Q3 financial report data shows that Huixuan's accumulated insured customers have exceeded 10 million.Hualu Hengsheng: The adipic acid plant of nylon 66 high-end new material project was put into production. Hualu Hengsheng (600426) announced on the evening of December 11th that the adipic acid plant of the company's nylon 66 high-end new material project had been put through the process, produced qualified products and entered the trial production stage. Production facilities such as nylon 66 are currently under construction. After the adipic acid plant is put into production, 200,000 tons/year of adipic acid can be added, which lays a foundation for the company to further expand the new chemical materials sector and is conducive to improving the comprehensive competitiveness of enterprises.
Kaidianbao suspended the payment business. On December 11th, Kaidianbao Payment Service Co., Ltd. announced that due to the change of business conditions, in order to protect the interests of merchants and partners to the greatest extent, the company decided to suspend the payment business, and from now on, the existing stock business will be withdrawn and cleaned in an orderly manner, and the businesses with potential risks will be cleaned up before December 20th, 2024. All stock payment services will be suspended after December 31, 2024. Regarding why the business was suspended, the reporter interviewed the legal representative of the company, but did not get a response from the other party. (beijing business today)The Israeli army warned Lebanese residents not to move to southern Lebanon. On the 11th local time, Adrahi, Arabic spokesperson of the Israel Defense Forces, posted a message on the social media platform, asking Lebanese residents not to move to more than 60 villages and their surrounding areas in southern Lebanon until further notice. The Israeli army provided a schematic diagram of the warning area and warned that anyone moving south of the area would put himself in danger. (CCTV News)In November, the loading capacity of power batteries was 67.2GWh, up 13.5% from the previous month. According to the data of China Automotive Power Battery Industry Innovation Alliance, the total output of power batteries and other batteries in China was 117.8GWh in November, up 4.2% from the previous month and 33.3% from the same period last year. The loading capacity of power batteries in China was 67.2GWh, up 13.5% from the previous month and 49.7% from the same period last year. Among them, the loading capacity of ternary batteries was 13.6GWh, accounting for 20.2% of the total car, up 11.6% from the previous month and down 13.5% from the same period last year. The loading capacity of lithium iron phosphate battery was 53.6GWh, accounting for 79.7% of the total vehicle, up 14.0% from the previous month and 84.0% from the same period last year.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
Strategy guide 12-14
Strategy guide